In research presented at Digestive Disease Week 2014, a review of 1,090 biopsy-confirmed nonalcoholic fatty liver disease (NAFLD) patients found that those who were overweight or obese actually had a lower overall mortality compared to lean patients. Taking samples at the time of the liver biopsy, the investigators found that total survival was significantly shorter in lean patients. Both lean and overweight patients had cardiovascular disease, malignancy, and liver problems as the primary mortality causes. The researchers urge physicians to encourage their lean NAFLD patients to increase their physical activity and modify their eating habits to lower the increased mortality risk.
GI & Hepatology News reports that lean patients with nonalcoholic fatty liver disease (NAFLD) have a higher overall mortality than overweight or obese patients with NAFLD, according to a review of 1,090 biopsy-confirmed patients in the U.S., Australia, Thailand and Europe. Reviewing blood and …
READ FULL ARTICLE
From www.gastro.org
Please login or register first to view this content.
